Covidien intends to expand Hyderabad Engineering R&D Center to 350 in three years

Covidien , Inc. a US-based manufacturer of medical devices and pharmaceuticals, and an Amritt client, has set up its first research and development center in Hyderabad, India. Business Line reported.

covidien RnD Hyderabad Inauguration

Randell Frazier inagurates Covidien India R&D Center, Rob Frechette, Anurag Asthana, Arjun Sarker in photo from left

“The Indian healthcare devices market is part of our focus on emerging markets. The Hyderabad center will enable us to improve product time to market and create valued-innovation,”  according to Robert Frechette, Vice-President (Engineering Services).

Stating that the company had over 14,000 patents worldwide, with another 12,000 patent applications pending, Frechette told the  Business Standard that  idea to set up an R&D center in India was primarily to support the company’s entire operations globally. Besides generating ideas from here, filing global patents from here was also on the cards, he said.

“We currently spend 5 per cent of our revenues on R&D, which we plan to increase to about 6 per cent starting this year,” he said, adding that the company had so far launched over 100 new products and expected to launch more than 50 products over the next two years.

Apart from designing products to suit local market needs, the R&D unit would utilise India’s huge talent pool to provide a range of engineering services for the company’s medical products business. The company plans to hire over 350 professionals for the centre over the next two years. Some 30 people are already working at the 40,000-square-foot facility.

Mr Arjun Sarker, Managing Director — Indian sub-continent, Covidien, said the business focus in India would be on surgical solutions and medical devices, though the company is strong in the pharmaceuticals business too.

Share:
  • del.icio.us
  • Facebook
  • LinkedIn
  • Twitter
Posted on by Gunjan
Gunjan Bagla
California-based management consultant Gunjan Bagla runs Amritt, a consulting firm helping American companies to succeed in India. Amritt is the trusted advisor for India market research, India business development, India market entry, Global Engineering, Global Technology Scouting, India R&D and Open Innovation. Gunjan is author of "Business in 21st Century India: How to Profit Today from Tomorrow’s Most Exciting Market" (Hachette Book Group, 2008), Amazon's top rated title on the subject. He has appeared as the India Expert on BBC Television, Bloomberg TV, Fox Cable Business and has been quoted in the New York Times, the Los Angeles Times, the Hollywood Reporter and Business Week for his expertise on India.

0 comments

There are no comments yet...

Kick things off by filling out the form below.

You must log in to post a comment.